Purple Innovation Earnings Calls
| Release date | Nov 04, 2025 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.0800 |
| EPS Surprise | 11.11% |
| Revenue estimate | 140.804M |
| Revenue actual | 118.766M |
| Revenue Surprise | -15.65% |
| Release date | Jul 29, 2025 |
| EPS estimate | -$0.120 |
| EPS actual | -$0.110 |
| EPS Surprise | 8.33% |
| Revenue estimate | 123.206M |
| Revenue actual | 105.1M |
| Revenue Surprise | -14.70% |
| Release date | May 06, 2025 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.110 |
| EPS Surprise | 21.43% |
| Revenue estimate | 114.07M |
| Revenue actual | 104.171M |
| Revenue Surprise | -8.68% |
| Release date | Mar 13, 2025 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.0700 |
| EPS Surprise | 50.00% |
| Revenue estimate | 129.069M |
| Revenue actual | 128.975M |
| Revenue Surprise | -0.0728% |
Last 4 Quarters for Purple Innovation
Below you can see how PRPL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 13, 2025 |
| Price on release | $0.664 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.0700 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| Mar 07, 2025 | $0.740 |
| Mar 10, 2025 | $0.694 |
| Mar 11, 2025 | $0.702 |
| Mar 12, 2025 | $0.706 |
| Mar 13, 2025 | $0.664 |
| Mar 14, 2025 | $0.90 |
| Mar 17, 2025 | $0.85 |
| Mar 18, 2025 | $0.83 |
| Mar 19, 2025 | $0.81 |
| 4 days before | -10.31% |
| 4 days after | 22.71% |
| On release day | 35.63% |
| Change in period | 10.06% |
| Release date | May 06, 2025 |
| Price on release | $0.744 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.110 |
| EPS surprise | 21.43% |
| Date | Price |
|---|---|
| Apr 30, 2025 | $0.677 |
| May 01, 2025 | $0.643 |
| May 02, 2025 | $0.661 |
| May 05, 2025 | $0.664 |
| May 06, 2025 | $0.744 |
| May 07, 2025 | $0.82 |
| May 08, 2025 | $0.81 |
| May 09, 2025 | $0.790 |
| May 12, 2025 | $0.94 |
| 4 days before | 9.93% |
| 4 days after | 26.34% |
| On release day | 10.22% |
| Change in period | 38.89% |
| Release date | Jul 29, 2025 |
| Price on release | $0.85 |
| EPS estimate | -$0.120 |
| EPS actual | -$0.110 |
| EPS surprise | 8.33% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $0.93 |
| Jul 24, 2025 | $0.86 |
| Jul 25, 2025 | $0.90 |
| Jul 28, 2025 | $1.00 |
| Jul 29, 2025 | $0.85 |
| Jul 30, 2025 | $0.82 |
| Jul 31, 2025 | $0.81 |
| Aug 01, 2025 | $0.81 |
| Aug 04, 2025 | $0.85 |
| 4 days before | -8.66% |
| 4 days after | -0.0118% |
| On release day | -3.84% |
| Change in period | -8.67% |
| Release date | Nov 04, 2025 |
| Price on release | $0.81 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.0800 |
| EPS surprise | 11.11% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $0.84 |
| Oct 30, 2025 | $0.795 |
| Oct 31, 2025 | $0.792 |
| Nov 03, 2025 | $0.797 |
| Nov 04, 2025 | $0.81 |
| Nov 05, 2025 | $0.719 |
| Nov 06, 2025 | $0.700 |
| Nov 07, 2025 | $0.83 |
| Nov 10, 2025 | $0.763 |
| 4 days before | -4.31% |
| 4 days after | -5.51% |
| On release day | -10.99% |
| Change in period | -9.59% |
Purple Innovation Earnings Call Transcript Summary of Q3 2025
Purple reported Q3 2025 revenue of $118.8M (roughly flat YoY) and achieved positive adjusted EBITDA for the quarter. Gross margin improved materially to ~42.8% (up ~700 bps sequentially), reflecting cost savings from the completed restructuring, sourcing shifts, and better warranty/scrap trends. Key commercial drivers included strong showroom performance (showroom net revenue +6.5%, 12% comps, 76% of showrooms profitable YTD), successful Rejuvenate 2.0 product launch (premium positioning, doubled unit sales vs. prior version), and expanded wholesale distribution—most notably the Mattress Firm rollout (≈9,200 slots now, on pace for 12,000 by March 2026; company projects ~$20M incremental revenue this year and ~$70M in 2026). E-commerce declined (~-10%) but showed sequential improvement after a site refresh and stronger Amazon fulfillment. Operating expenses were down ~23% YoY; adjusted operating expenses down ~8.6% YoY. Cash was $32.4M at quarter end and inventories rose modestly. Management reiterated FY2025 guidance of $465–485M revenue and adjusted EBITDA between breakeven and $10M positive, expects Q4 gross margin around ~40%, and sees a path to positive cash generation in 2026. The Board is conducting a review of strategic alternatives (e.g., merger or sale) and the process remains ongoing. Overall, investors should note margin recovery and cost structure improvements driving near-term profitability while growth initiatives (product innovation, Mattress Firm/Costco expansion, marketing) aim to accelerate top-line growth into 2026.
Sign In
Buy PRPL